Home » Topics » Regulatory » Patents

Patents
RSS

Emory University discloses RNA-directed RNA polymerase inhibitors

Sep. 27, 2016

Novartis patents angiotensin AT2 receptor antagonists

Sep. 27, 2016

Bristol-Myers Squibb develops ROCK2 inhibitors

Sep. 26, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Merck & Co. discloses IRAK-4 inhibitors

Sep. 26, 2016

Aurigene Discovery Technologies patents PD-1 signaling inhibitors

Sep. 26, 2016

GlaxoSmithKline prepares and tests bromodomain-containing protein inhibitors

Sep. 23, 2016

Dana-Farber Cancer Institute reports MELK inhibitors

Sep. 23, 2016

Alpharmagen patents nicotinic acetylcholine alpha7 receptor positive allosteric modulators

Sep. 23, 2016

Pharmakea describes LOXL2 inhibitors

Sep. 23, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...